《改善急性冠状动脉综合征患者预后研究（IMPROVE-IT）试验在当前患者中的适用性：一项 NCDR 研究到实践项目》。
Applicability of the IMPROVE-IT Trial to Current Patients With Acute Coronary Syndrome: An NCDR Research to Practice Project.
机构信息
VA Eastern Colorado Health Care System, Denver2University of Colorado School of Medicine, Denver3Colorado Cardiovascular Outcomes Research (CCOR) Consortium, Denver.
Mid-America Heart Institute, Kansas City, Missouri.
出版信息
JAMA Intern Med. 2017 Jun 1;177(6):887-889. doi: 10.1001/jamainternmed.2017.0754.
Abstract
This study examines the proportion of current patients with acute coronary syndrome in the American College of Cardiology practice innovation and clinical excellence ambulatory cardiology practice registry that would have qualified for the IMPROVE-IT trial, and how their characteristics compared with trial participants.
摘要
本研究考察了美国心脏病学会实践创新和临床卓越门诊心脏病学实践登记处中目前患有急性冠状动脉综合征的患者中，有多少比例符合 IMPROVE-IT 试验的条件，以及他们的特征与试验参与者相比如何。
相似文献
1
Applicability of the IMPROVE-IT Trial to Current Patients With Acute Coronary Syndrome: An NCDR Research to Practice Project.《改善急性冠状动脉综合征患者预后研究（IMPROVE-IT）试验在当前患者中的适用性：一项 NCDR 研究到实践项目》。
JAMA Intern Med. 2017 Jun 1;177(6):887-889. doi: 10.1001/jamainternmed.2017.0754.
2
Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria.基于 IMPROVE-IT 标准的依泽替米贝治疗的意义。
Am J Med. 2015 Nov;128(11):1253-6. doi: 10.1016/j.amjmed.2015.05.027. Epub 2015 Jun 10.
3
[The IMPROVE-IT trial].[IMPROVE-IT试验]
G Ital Cardiol (Rome). 2015 Dec;16(12):667-71. doi: 10.1714/2088.22578.
4
Did we IMPROVE-IT: thoughts on LDL targeting post-trial?我们是否改进了依折麦布与辛伐他汀治疗对心血管事件的影响（IMPROVE-IT）试验：试验后关于低密度脂蛋白（LDL）靶向治疗的思考？
Expert Rev Cardiovasc Ther. 2015 May;13(5):465-6. doi: 10.1586/14779072.2015.1034978. Epub 2015 Apr 12.
5
[The IMPROVE-IT trial showed no favorable effects on well-defined and clinically relevant endpoints].IMPROVE-IT试验对明确且具有临床相关性的终点未显示出有益效果。
G Ital Cardiol (Rome). 2015 Dec;16(12):739. doi: 10.1714/2088.22594.
6
[Letter].[信件]
G Ital Cardiol (Rome). 2015 Dec;16(12):739-40. doi: 10.1714/2088.22576.
7
Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.依折麦布联合辛伐他汀使双重低密度脂蛋白胆固醇和高敏 C 反应蛋白目标达标更频繁，并改善 IMPROVE-IT 结局。
Circulation. 2015 Sep 29;132(13):1224-33. doi: 10.1161/CIRCULATIONAHA.115.018381. Epub 2015 Sep 1.
8
Can Clinicians Improve on the Effectiveness of Statins with Additional Lipid-lowering Therapies?临床医生能否通过额外的降脂疗法提高他汀类药物的疗效？
Am J Med. 2015 Nov;128(11):1160-1. doi: 10.1016/j.amjmed.2015.06.027. Epub 2015 Jul 14.
9
[ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].[急性冠状动脉综合征与降脂治疗。IMPROVE-IT研究有何不同？]
Rev Med Liege. 2015 Sep;70(9):450-5.
10
Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT".对关于文章《在辛伐他汀中添加依折麦布更频繁地实现双重低密度脂蛋白胆固醇和高敏C反应蛋白目标，并与IMPROVE-IT研究中的更好结局相关》的信件的回复
Circulation. 2016 Mar 29;133(13):e463. doi: 10.1161/CIRCULATIONAHA.116.020947.
引用本文的文献
1
Projected Outcomes of Optimized Statin and Ezetimibe Therapy in US Military Veterans with Coronary Artery Disease.优化他汀类药物和依折麦布治疗对美国冠心病退伍军人的预期结果。
JAMA Netw Open. 2023 Aug 1;6(8):e2329066. doi: 10.1001/jamanetworkopen.2023.29066.
本文引用的文献
1
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.依折麦布联合他汀类药物治疗急性冠脉综合征。
N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.
2
The Capacity of Evidence to Inform Practice: The Rapid Registry Response (RRR) Initiative.为实践提供信息的证据能力：快速登记响应（RRR）倡议。
J Am Coll Cardiol. 2015 May 26;65(20):2252-3. doi: 10.1016/j.jacc.2015.04.007.
3
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会成人降低动脉粥样硬化性心血管风险的血胆固醇治疗指南：美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12.
Zotero 插件